attyloid GmbH
- Biotech or pharma, therapeutic R&D
- Diagnostics
attyloid’s sFIDA platform technology offers a cutting-edge approach for quantification and sizing of oligomers and aggregates, which serve as biomarkers of neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s Disease.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}